Scale-up, sterility assurance, critical quality attributes and stability programmes decide whether a promising delivery system ever reaches a patient. We design for these from the first batch.
How we work on it
Every programme in this area follows the same staged path: target definition, carrier or formulation engineering, validation in physiologically relevant models, then transfer to continuous-flow GMP production. Read the full technology overview or talk to the team.